Trial Profile
AN EXPLORATORY STUDY TO INVESTIGATE THE BIOAVAILABILITY AND PHARMACODYNAMICS OF DUPILUMAB IN DERMAL INTERSTITIAL FLUID OF ATOPIC DER-MATITIS PATIENTS
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Sep 2023
Price :
$35
*
At a glance
- Drugs Dupilumab (Primary)
- Indications Atopic dermatitis
- Focus Pharmacodynamics
- 26 Nov 2021 Status changed from recruiting to completed.
- 13 Dec 2018 New trial record